Insider Trading History of Goldstein Joseph L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Goldstein Joseph L since year 2005. The trader's CIK number is 1225474. At the time of the last reporting, Goldstein Joseph L was the Director of Regeneron Pharmaceuticals, Inc. . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Goldstein Joseph L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-11-27 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 370.00 370,000
2019-11-27 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 33.42 33,420
2019-11-22 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 360.00 360,000
2019-11-21 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 33.42 33,420
2019-11-22 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 33.42 33,420
2019-11-21 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 350.00 350,000
2019-11-08 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 340.44 340,440
2019-05-15 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 305.93 305,930
2019-01-10 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,791 273.67 490,142
2019-01-10 REGN Regeneron Pharmaceuticals, Inc. Sale 1,791 410.00 734,310
2018-09-27 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 273.67 547,340
2018-09-27 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 400.00 800,000
2018-09-28 REGN Regeneron Pharmaceuticals, Inc. Option Ex 709 273.67 194,032
2018-09-28 REGN Regeneron Pharmaceuticals, Inc. Sale 709 410.00 290,690
2018-09-24 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 273.67 547,340
2018-09-24 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 388.64 777,290
2018-08-02 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 57.11 114,220
2018-08-02 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 380.00 760,000
2018-07-05 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 57.11 114,220
2018-07-06 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 370.00 740,000
2018-07-05 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 360.00 720,000
2018-07-06 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 57.11 114,220
2018-03-19 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 57.11 114,220
2018-03-19 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 350.02 700,040
2018-03-14 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 57.11 114,220
2018-03-14 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 340.00 680,000
2017-06-20 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 500.01 500,010
2017-06-20 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 273.67 273,670
2017-06-09 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 482.55 482,550
2017-06-09 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 273.67 273,670
2016-11-14 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,125 273.67 581,548
2016-11-14 REGN Regeneron Pharmaceuticals, Inc. Sale 2,125 450.00 956,250
2016-07-29 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,125 273.67 581,548
2016-07-29 REGN Regeneron Pharmaceuticals, Inc. Sale 2,125 425.00 903,125
2016-04-06 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 425.00 850,000
2016-04-06 REGN Regeneron Pharmaceuticals, Inc. Option Ex 1,000 177.82 177,820
2016-04-01 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 400.00 800,000
2016-04-01 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 177.82 355,640
2016-03-21 REGN Regeneron Pharmaceuticals, Inc. Option Ex 2,000 177.82 355,640
2016-03-21 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 375.00 750,000
2015-08-04 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 586.00 1,172,000
2015-07-15 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 550.00 1,100,000
2015-06-22 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 526.85 1,053,700
2015-05-22 REGN Regeneron Pharmaceuticals, Inc. Sale 4,000 514.27 2,057,100
2015-02-20 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 177.82 889,100
2015-02-20 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 423.88 2,119,375
2014-11-12 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 177.82 889,100
2014-11-12 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 398.31 1,991,550
2014-08-27 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 350.31 700,620
2014-08-06 REGN Regeneron Pharmaceuticals, Inc. Sale 2,000 331.20 662,400
2014-02-25 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 338.86 338,860
2014-02-20 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 327.09 327,090
2014-02-12 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 320.62 320,620
2013-11-06 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 300.74 300,740
2013-08-23 REGN Regeneron Pharmaceuticals, Inc. Sale 1,000 238.29 238,290
2013-05-28 REGN Regeneron Pharmaceuticals, Inc. Sale 4,000 252.20 1,008,800
2013-04-01 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 24.41 122,050
2013-04-01 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 180.00 900,000
2013-01-09 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 57.11 285,550
2013-01-09 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 185.00 925,000
2013-01-04 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 180.86 904,300
2013-01-04 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 33.42 167,100
2012-03-26 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 120.00 600,000
2012-03-26 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 18.61 93,050
2012-03-15 REGN Regeneron Pharmaceuticals, Inc. Sale 10,000 112.28 1,122,770
2012-03-15 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 18.61 186,100
2012-02-14 REGN Regeneron Pharmaceuticals, Inc. Sale 15,000 110.02 1,650,300
2012-02-14 REGN Regeneron Pharmaceuticals, Inc. Option Ex 15,000 28.91 433,725
2012-01-19 REGN Regeneron Pharmaceuticals, Inc. Sale 10,000 80.00 800,000
2012-01-10 REGN Regeneron Pharmaceuticals, Inc. Sale 20,000 74.57 1,491,339
2012-01-10 REGN Regeneron Pharmaceuticals, Inc. Option Ex 20,000 21.07 421,460
2011-10-14 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 23.84 238,400
2011-10-14 REGN Regeneron Pharmaceuticals, Inc. Sale 10,000 65.00 650,000
2011-07-01 REGN Regeneron Pharmaceuticals, Inc. Sale 10,000 56.16 561,550
2011-07-01 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 28.81 288,100
2011-05-04 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 28.81 144,050
2011-05-04 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 48.89 244,450
2011-03-21 REGN Regeneron Pharmaceuticals, Inc. Sale 11,505 40.00 460,200
2011-03-09 REGN Regeneron Pharmaceuticals, Inc. Option Ex 15,000 9.17 137,550
2011-02-11 REGN Regeneron Pharmaceuticals, Inc. Sale 2,761 36.66 101,218
2011-02-10 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 15.80 79,000
2011-01-26 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 15.80 158,000
2011-01-27 REGN Regeneron Pharmaceuticals, Inc. Sale 5,401 34.67 187,252
2010-12-17 REGN Regeneron Pharmaceuticals, Inc. Sale 5,281 32.00 168,992
2010-12-16 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 15.01 150,100
2010-11-24 REGN Regeneron Pharmaceuticals, Inc. Sale 4,331 30.06 130,189
2010-11-23 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 16.91 169,050
2010-10-04 REGN Regeneron Pharmaceuticals, Inc. Option Ex 10,000 18.80 188,000
2010-05-17 REGN Regeneron Pharmaceuticals, Inc. Sale 400 28.06 11,224
2010-05-14 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 25.43 127,150
2008-10-01 REGN Regeneron Pharmaceuticals, Inc. Sale 500 22.32 11,160
2008-01-22 REGN Regeneron Pharmaceuticals, Inc. Sale 5,000 25.00 125,000
2008-01-22 REGN Regeneron Pharmaceuticals, Inc. Option Ex 5,000 7.66 38,300
2007-11-05 REGN Regeneron Pharmaceuticals, Inc. Sale 800 20.71 16,569
2007-11-05 REGN Regeneron Pharmaceuticals, Inc. Option Ex 4,200 7.66 32,172
2007-11-05 REGN Regeneron Pharmaceuticals, Inc. Sale 4,200 20.53 86,234
2007-11-05 REGN Regeneron Pharmaceuticals, Inc. Option Ex 800 7.66 6,128

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldstein Joseph L (Director of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month